Bruker`s New Software and Informatics Solutions to Empower Metabolomics, Proteoform Profiling, and Toxicology

Bruker showcased a number of analytical solutions this year at ASMS as they celebrate 25 years of MALDI technology innovation. The new offerings for life science, translational, and pharmaceutical research applications are meant to enhance the quality and depth of data analysis and interpretation.

Bruker’s advanced MALDI Imaging platform now integrates the SCiLS software with the rapifleX high-throughput MALDI-TOF/TOF or the novel MALDI-Magnetic Resonance Mass Spectrometry (MRMS) system for drug and metabolite imaging. The SCiLS Cloud and SCiLS Lab software solutions bring new features and capabilities to the MALDI Imaging platforms.

Metaboscape 3.0 is a third-generation metabolomics research and validation solution. The software supports direct injection (DI) and MALDI Magnetic Resonance Mass Spectrometry (MRMS) for high-throughput translational research analysis and validation. The software is fitted with several advanced algorithms and features aimed at extracting all relevant information with precision and speed. The effect will be higher throughput for validating larger sample cohorts in larger-scale longitudinal studies.

Also announced were the TargetScreener 3.0HR and ToxTyper 2.0E, both for screening and quantitation in Forensics, Food Safety, and Environmental Testing applications.

Bruker also released the nanoElute nano-flow UHPLC system. This device is meant to work in concert with Proteoform Profiling and other metabolomics software to capture greater depth of label-free intact proteins in discovery workflows.

These new releases follow on the heels of several exciting instrument platform announcements made at Pittcon earlier this year. Bruker seems to be offering tools and solutions aimed at all angles of the MS field.